Lane 1: 293T
Lane 2: A431
Lane 3: Mouse heart
Recombinant Rabbit monoclonal primary
Recombinant PDHA1 Monoclonal Antibody (ET1702-75)
Rat kidney tissue lysate, mouse stomach tissue lysate, 293T cell lysate, A431 cell lysate, mouse heart tissue lysate, Hela, HepG2, SH-SY5Y, human breast carcinoma tissue, human kidney tissue, mouse skeletal muscle tissue, human lung carcinoma tissue, mouse colon tissue, mouse stomach tissue.
Store at +4C after thawing. Aliquot store at -20C or -80C. Avoid repeated freeze / thaw cycles.
1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Protein A affinity purified.
ODPA_HUMAN antibody; PDH antibody; PDHA antibody; PDHA1 antibody; PDHCE1A antibody; PDHE1 A type I antibody; PDHE1-A type I antibody; PHE1A antibody; Pyruvate Dehydrogenase (lipoamide) alpha 1 antibody; Pyruvate dehydrogenase complex, E1 alpha polypeptide 1 antibody; Pyruvate Dehydrogenase E1 alpha antibody; Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial antibody
Phosphorylation at Ser-232, Ser-293 and Ser-300 by PDK family kinases inactivates the enzyme; for this phosphorylation at a single site is sufficient. Dephosphorylation at all three sites, i.e. at Ser-232, Ser-293 and Ser-300, is required for reactivation.; Acetylation alters the phosphorylation pattern. Deacetylated by SIRT3 (By similarity).
The pyruvate dehydrogenase (PDH) complex is a nuclear-encoded mitochondrial matrix enzyme complex that functions as the primary link between glycolysis and the tricarboxylic acid (TCA) cycle by catalyzing the irreversible conversion of pyruvate into acetyl-CoA. The E1 enzyme of the PDH complex is made up of a heterotetramer of two α and two β subunits. The E1-α subunit (PDH-E1α) contains the E1 active site and plays a key role in the function of the PDH complex. The PDH complex is regulated by phosphorylation and dephosphorylation of PDH-E1α. The gene encoding for PDH-E1α maps to chromosome Xp22.12, and a 20bp deletion in the last exon of this gene is sufficient to cause PDH deficiency, which causes a broad range of symptoms including the development of seizures, mental retardation and spasticity, as well as intermittent episodes of lactic acidosis associated with cerebellar ataxia.